Idarucizumab for Dabigatran Reversal-full Cohort Analysis (RE-VERSE AD Study)
Journal Title: UNKNOWN - Year 2018, Vol 24, Issue 2
Abstract
.
Authors and Affiliations
Esme Ekizoğlu
Keywords
Related Articles
- EP ID EP368890
- DOI 10.4274/tnd.37233
- Views 85
- Downloads 0
Nutritional Approach and Treatment in Patients with Stroke, An Expert Opinion for Turkey
Cerebrovascular diseases comprise the most common category of inpatient cases taken care of by neurologists. Dysphagia and malnutrition are not rare after stroke. It is strongly recommended for neurologists to screen and...
Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years
With the advent of new agents in the treatment of multiple sclerosis, new treatment modalities have emerged (escalation-induction therapy) and the increased efficacy of the drugs has led to increased drug-related risks....
Hospital Infection Rates in a Neurology Intensive Care Unit in a One-year Period: Pathogenic and Clinical Evaluation
Objective: Nosocomial infections (NI) are serious threats for patients, especially those treated in intensive care units (ICU), which have high risk. Therefore, determining the infectious agents in this area and treating...
Neurological Manifestation of Legionnaire’s Disease
.
A Treatable Reason of Myopathy: Hypothyroidism
.